Healthy Clinical Trials

1. Measurement of Immunological Responses from Human Blood of Healthy Donors
2. A randomized, double-blind, placebo-controlled Phase II study to evaluate safety and immunogenicity of one and two doses of IMVAMUNE® smallpox vaccine in 56-80 year old vaccinia-experiences subjects.
3. Phase I evaluation of the safety and immunogenicity of a replication-competent adenovirus serotype 4-vectored H5N1 influenza candidate vaccine - Ad4-H5-Vtn. An oral vaccine for bird flu.
4. Collection of peripheral blood mononuclear cells from normal donors for development of immune assays